Toronto Dominion Bank
HAE icon

Toronto Dominion Bank’s Haemonetics HAE Stock Holding History

Toronto Dominion Bank’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-9
Closed -$806 – 1671
2023
Q3 		$806 Hold
9
– – ﹤0.01% 1445
2023
Q2 		$1K Buy
+9
New +$761 ﹤0.01% 1413
2022
Q2 		– Sell
-7,600
Closed -$480K – 1563
2022
Q1 		$480K Buy
7,600
+7,597
+253,233% +$413K ﹤0.01% 1050
2021
Q4 		$0 Buy
+3
New +$183 ﹤0.01% 1711
2021
Q1 		– Sell
-300
Closed -$36K – 1497
2020
Q4 		$36K Hold
300
– – ﹤0.01% 1186
2020
Q3 		$26K Hold
300
– – ﹤0.01% 1075
2020
Q2 		$27K Buy
+300
New +$30.3K ﹤0.01% 1095

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Toronto Dominion Bank's HAE Position: Q4 2023 in Review

Toronto Dominion Bank sold out of Haemonetics (HAE) in Q4 2023, closing a stake of 9 shares — an estimated $806 sold.

Toronto Dominion Bank first reported a position in HAE in Q2 2020 and held it in 7 quarters. The position peaked at $480K in Q1 2022. 295 funds tracked by Wall St. Rank hold HAE as of Q4 2023.

  • Toronto Dominion Bank reported no remaining Haemonetics position as of Q4 2023 after selling out during the quarter.
  • Toronto Dominion Bank sold 9 Haemonetics shares in Q4 2023, an estimated $806.
  • Toronto Dominion Bank first reported a position in Haemonetics in Q2 2020 and held it in 7 quarters.
  • Toronto Dominion Bank's Haemonetics position peaked at $480K in Q1 2022.
  • 295 funds tracked by Wall St. Rank held Haemonetics as of Q4 2023.

Based on Toronto Dominion Bank's 13F filing for Q4 2023, filed 13 Feb 2024.